Schizophrenia and Related DisordersNCT04655287
A Register Study of Effects Following Local Variation in Rates of Involuntary Care
An observational study of Schizophrenia and Related Disorders and Bipolar Disorder, run by University Hospital, Akershus.
Trial summary
Involuntary mental health care is permitted because it is believed to make people with severe mental disorders (SMD) better and prevent them from getting worse or even dying In this study we will investigate whether low levels of coercion in an area is connected with poorer outcomes in Norway. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Schizophrenia and Related Disorders, Bipolar Disorder
- How many people
- 21,759 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2015to 31 Dec 2018
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Norwegian adults from 18-65 years that had at least one specialist inpatient or outpatient treatment episode with a registered diagnosis of F20-31 according to International Classification of Diseases (ICD-10) in 2015. Persons without permanent residence in Norway is excluded. The sample is the full target population, based on a mandatory national patient registry.
Who may be able to join
- The person received treatment for ICD-10 codes F20-31 in Norwegian health trusts 2015
Who cannot join
- Persons without permanent address in Norway (tourists)
- For models 2 and 3, patients receiving involuntary mental health care in 2015 is excluded
About this study
Official title: Do Low Rates of Coercion in Catchment Areas Predict Negative Effects for Persons With Severe Mental Disorders? A Register Study From Norway 2015-2017. Part of Reducing Coercion in Norway (ReCoN)
Involuntary mental health care is permitted because it is believed to make people with severe mental disorders (SMD) better and prevent them from getting worse or even dying In this study we will investigate whether low levels of coercion in an area is connected with poorer outcomes in Norway. It can be assumed that too little involuntary care might lead to the opposite outcomes to those intended by the Norwegian Mental Health Act.
The same law applies all over Norway, but the rate of involuntary care varies: there is up to five-fold difference between the catchment areas of the 69 Community Mental Health Centers. The investigators will estimate rates of involuntary care and adjust for age, sex, urbanity and area deprivation. The data source is the Norwegian Patients Registry, and all patients in treatment for a severe mental disorder in 2015 and their use of mental health care until 2018 will be followed.
Read more
Model 1 follows all patients who were treated for a severe mental disorder in 2015. The model will test whether the rates of involuntary care in the area they live can predict the length of time to death.
Model 2 follows patients with treatment for severe mental disorders that had no episode of involuntary care in 2015. The model will test whether the rate of involuntary care in their area predicts their use of mental health inpatient care in 2016 and 2017.
Model 3 tests how long time patients with severe mental disorders that received only voluntary care in 2015 remain without a period of involuntary care in 2016-17, as a function of the rate of involuntary care in their area in 2015.
Model 4 estimates changes in the total number of patients with severe mental disorders in the catchment area in 2016-17 as a function of time and the rate of involuntary in 2015.
Model 5 tests whether suicide rates for a catchment area varies as a function of its rate of involuntary care. Because suicides are rare, we will observe the variables over longer time periods, using involuntary care rates from 2015 to 2018 and suicide rates for 2015-2019.
The study was evaluated by the Research Ethics Committee (ref 2018/795), who approved use of registry data, and by the Privacy Ombudsman at Akershus University Hospital (ref 2018-090).
Read the detailed description
Involuntary mental health care is permitted because it is believed to make people with severe mental disorders (SMD) better and prevent them from getting worse or even dying. This study concerns whether low levels of coercion in an area is connected with poorer outcomes in Norway. Too little involuntary care could be expected to lead to the opposite outcomes to those intended by the Norwegian Mental Health Act.
The same law applies all over Norway, but the rate of involuntary care varies: there is an up to five-fold difference between the catchment areas of the 69 Community Mental Health Centers (CMHC).
This study will use national register data to test whether areas with low rates of involuntary care shows signs of failing to achieve the patient benefits of involuntary care as intended by the Norwegian Mental Health Act.
Data on involuntary care will be retrieved from the Norwegian Patient Registry (NPR) and combined with data on the general population and demographics from Statistics Norway, to study the hypothesized negative consequences of low rates of involuntary care. All of Norway's 21 Health Trusts and their 69 Community Mental Health Centers that provide specialist services are required to submit to NPR on an annual basis complete data of all service use from their hospitals' electronic patient administrative and clinical systems. The NPR conducts extensive data-quality checks, and publishes completeness data for all variables. The registry implemented a unique patient identifier in 2008, so that a patient's care can be followed across time. From the NPR database, information on all specialist mental health treatment activity for patients with set criteria (in our case diagnosis F20-31 and legal status) during a given time period (here 2015-18) can be extracted.
Both involuntary admissions and outpatient compulsion in the form of community treatment orders (CTO) are envisaged to contribute to the aims of the Mental Health Act, such as protection against harm, improvement, restoration of health, and recovery or cure for the patient. The variable of interest is low use of the combination of these two forms of involuntary care. To our knowledge, there is no established way to calculate a combined measure of inpatient and outpatient involuntary care, and it is not generally established how one form of involuntary care is associated with the other. In Norway, 31% of involuntary admissions continued as a CTO in 2018, and although permitted, CTOs are almost never initiated when the patient lives at home. When a patient is under involuntary admissions or a CTO, the care system has substantial influence and control over their treatment, and medication is a particular focus. Regardless of the form of involuntary care, control over treatment can be continued according to necessity criteria in the law in order to prevent deterioration. For these reasons, the rate of persons affected by involuntary admission and/or CTO per 100 000 capita will be used as an indicator of use of involuntary care in the catchment area and hence, the main covariate.
The age span will be patients from 18 to 65, so that the increasing frequency of involuntary care due to lack of capacity due to dementia towards the end of life will not impact the results. The investigators will control for age and sex by indirect standardization, based on Statistics Norway's tables for population in municipalities and city districts.
The investigators will test whether the living condition index and/or urbanity of the municipality (perhaps merged to fewer categories than five) predict rates of involuntary care. A classification of all municipalities into five degrees of urbanity from a previous study will be used. Statistics Norway published an index of living conditions in Norwegian municipalities and City districts in 2000 and 2008, which has not been continued after 2008. This index combines the level or frequency of a variety of social benefit payments, unemployment, education level and lethality, and should be sufficiently up to date. If urbanity or living condition predicts rates of involuntary care, it will be controlled for by estimating a suitable linear regression model. A hierarchical model adjusting for nesting of municipalities within CMHCs and CMHCs within health trusts will be considered, but this adjustment may be reduced based on intraclass correlations. Then the ratio between expected and observed use of involuntary care will be the main covariate, and will reflect the rate of involuntary care per capita, controlled for age, sex and urbanity and deprivation in each catchment area. Each patient in the dataset will be assigned the value of this covariate corresponding to their area of residence in 2015.
The first group of models is assessing associations between the main covariate measured in the index year and survival or change in outcome variables in the following years for the patients included.
Model 1. Are there more deaths among SMD patients from areas with low levels of involuntary care?
The main covariate is rate of involuntary care in 69 areas in 2015, controlled for age, sex, urbanity and deprivation. The unit of analysis is the individual patient with a care episode and a registered SMD diagnosis in 2015. Outcome variable is time to death from the quarter in 2015 with a registered event with a SMD-diagnosis, observed through 2018. The unit of analysis is the individual SMD patient. The statistical method is survival analysis with adjustment for age and sex and adjustment for random effects.
Model 2. Is there increased use of inpatient care for voluntary SMD-patients from areas with low levels of involuntary care?
The main covariate is rate of involuntary mental health care in 69 areas in 2015, controlled for age, sex, urbanity and deprivation. The unit of analyses is the individual SMD-patient with 'voluntary care only' in 2015. The outcome variable is change in mental health inpatient days in the next two years for the included patients. The statistical method is a linear mixed model with random effects for CMHC.
Model 3. Is there decreased time to the next episode of involuntary care for voluntary SMD-patients from areas with low levels of involuntary care? The main covariate is rate of involuntary mental health care in the 69 areas in 2015, controlled for age, sex, urbanity and deprivation. The unit of analyses is the individual SMD-patient with 'voluntary care only' in 2015. Outcome variable are time to a treatment episode with involuntary care observed through 2016 and 2017. The statistical method is survival analysis with death as competing risk with random effects for catchment area.
Model 4 and 5 are ecological models of the catchment areas.
Model 4. Are low levels of involuntary care in a catchment area followed by more SMD patients in the area? The main covariate is rate of involuntary mental health care in the 69 areas in 2015, controlled for age, sex, urbanity and deprivation. The outcome variable is the change in annual number of patients with SMD in 2016 and 2017. The unit of analysis is the catchment area (N=69). The statistical method is linear regression model with time, main covariate and interaction between the two as independent variables.
Model 5. Is low level of involuntary care in an area related to more suicides?
The main covariate is rate of involuntary care in 2015-2018 in the 69 areas, controlled for age, sex, urbanity and deprivation. The outcome variable is the standardized rate of suicides in the area's population regardless of patient status, from 2015 through 2019. The unit of analysis is the 69 catchment areas. Due to low incidence of the outcome, merging of some areas will be considered. The statistical method is correlation analysis.
Dissemination: Study results will be published study international peer-reviewed scientific journals. The number of papers necessary to disseminate results depends of the complexity of results and their interpretation.
- Keywords
- Involuntary care, Mental health care act, Coercion, Psychiatric care
- Medical subject headings
- Schizophrenia, Bipolar Disorder
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to death
Time to death for patients with a severe mental disorder in 2015, as a function of the rate of involuntary care for the patient's area of residence in 2015
Measured: 2015-2017
Mental health inpatient days
Time trends in mental health inpatient days from 2015-2017 for patients with a severe mental disorder but no involuntary care in 2015, as a function of the rate of involuntary care for the patient's area of residence in 2015
Measured: 2015-2017
Episode of involuntary care
Time to an episode of involuntary care for patients with a severe mental disorder and no involuntary care in 2015, as a function of the rate of involuntary care for the patient's area of residence in 2015
Measured: 2015-2017
Number of patients with severe mental disorders
Time trends in the rate of severe mental disorders in 69 catchment areas as a function of their rates of involuntary care in 2015-2018
Measured: 2015-2017
Number of suicides
Standardized rate of suicides in 60 catchment areas in 2015-2019, as a function of rates of involuntary care in 2015-2018
Measured: 2015-2019
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Dec 2020
- Study start1 Jan 2015
- Primary completion31 Dec 2018
- Study completion31 Dec 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Schizophrenia and Related DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 21,759 participants (actual)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- University Hospital, Akershus
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Olav Nyttingnes, University Hospital, Akershus
- Investigators
- Jorun Rugkåsa, PhD, Principal investigator, University Hospital, Akershus
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04655287
- Sponsor's protocol ID
- 2018/795(REK)
- Other IDs
- 2018-090
- Status last verified
- Jan 2025
- First submitted
- 30 Nov 2020
- Last updated
- 29 Jan 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Nyttingnes O, Benth JS, Hofstad T, Rugkasa J. The relationship between area levels of involuntary psychiatric care and patient outcomes: a longitudinal national register study from Norway. BMC Psychiatry. 2023 Feb 20;23(1):112. doi: 10.1186/s12888-023-04584-4.
PubMed 36803444
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Do Low Rates of Coercion in Catchment Areas Predict Negative Effects for Persons With Severe Mental Disorders? A Register Study From Norway 2015-2017. Part of Reducing Coercion in Norway (ReCoN)
- ClinicalTrials.gov ID
- NCT04655287
- Acronym / sponsor ID
- 2018/795(REK)
- Keywords
- Involuntary care, Mental health care act, Coercion, Psychiatric care
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 21,759 participants (actual)
- Lead sponsor
- University Hospital, AkershusUniversity, hospital or other
- Study start
- 1 Jan 2015 (actual)
- Primary completion
- 31 Dec 2018 (actual)
- Study completion
- 31 Dec 2018 (actual)
- First posted
- 7 Dec 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Involuntary mental health care is permitted because it is believed to make people with severe mental disorders (SMD) better and prevent them from getting worse or even dying In this study we will investigate whether low levels of coercion in an area is connected with poorer outcomes in Norway. It can be assumed that too little involuntary care might lead to the opposite outcomes to those intended by the Norwegian Mental Health Act.
The same law applies all over Norway, but the rate of involuntary care varies: there is up to five-fold difference between the catchment areas of the 69 Community Mental Health Centers. The investigators will estimate rates of involuntary care and adjust for age, sex, urbanity and area deprivation. The data source is the Norwegian Patients Registry, and all patients in treatment for a severe mental disorder in 2015 and their use of mental health care until 2018 will be followed.
Model 1 follows all patients who were treated for a severe mental disorder in 2015. The model will test whether the rates of involuntary care in the area they live can predict the length of time to death.
Model 2 follows patients with treatment for severe mental disorders that had no episode of involuntary care in 2015. The model will test whether the rate of involuntary care in their area predicts their use of mental health inpatient care in 2016 and 2017.
Model 3 tests how long time patients with severe mental disorders that received only voluntary care in 2015 remain without a period of involuntary care in 2016-17, as a function of the rate of involuntary care in their area in 2015.
Model 4 estimates changes in the total number of patients with severe mental disorders in the catchment area in 2016-17 as a function of time and the rate of involuntary in 2015.
Model 5 tests whether suicide rates for a catchment area varies as a function of its rate of involuntary care. Because suicides are rare, we will observe the variables over longer time periods, using involuntary care rates from 2015 to 2018 and suicide rates for 2015-2019.
The study was evaluated by the Research Ethics Committee (ref 2018/795), who approved use of registry data, and by the Privacy Ombudsman at Akershus University Hospital (ref 2018-090).
Detailed description
Involuntary mental health care is permitted because it is believed to make people with severe mental disorders (SMD) better and prevent them from getting worse or even dying. This study concerns whether low levels of coercion in an area is connected with poorer outcomes in Norway. Too little involuntary care could be expected to lead to the opposite outcomes to those intended by the Norwegian Mental Health Act.
The same law applies all over Norway, but the rate of involuntary care varies: there is an up to five-fold difference between the catchment areas of the 69 Community Mental Health Centers (CMHC).
This study will use national register data to test whether areas with low rates of involuntary care shows signs of failing to achieve the patient benefits of involuntary care as intended by the Norwegian Mental Health Act.
Data on involuntary care will be retrieved from the Norwegian Patient Registry (NPR) and combined with data on the general population and demographics from Statistics Norway, to study the hypothesized negative consequences of low rates of involuntary care. All of Norway's 21 Health Trusts and their 69 Community Mental Health Centers that provide specialist services are required to submit to NPR on an annual basis complete data of all service use from their hospitals' electronic patient administrative and clinical systems. The NPR conducts extensive data-quality checks, and publishes completeness data for all variables. The registry implemented a unique patient identifier in 2008, so that a patient's care can be followed across time. From the NPR database, information on all specialist mental health treatment activity for patients with set criteria (in our case diagnosis F20-31 and legal status) during a given time period (here 2015-18) can be extracted.
Both involuntary admissions and outpatient compulsion in the form of community treatment orders (CTO) are envisaged to contribute to the aims of the Mental Health Act, such as protection against harm, improvement, restoration of health, and recovery or cure for the patient. The variable of interest is low use of the combination of these two forms of involuntary care. To our knowledge, there is no established way to calculate a combined measure of inpatient and outpatient involuntary care, and it is not generally established how one form of involuntary care is associated with the other. In Norway, 31% of involuntary admissions continued as a CTO in 2018, and although permitted, CTOs are almost never initiated when the patient lives at home. When a patient is under involuntary admissions or a CTO, the care system has substantial influence and control over their treatment, and medication is a particular focus. Regardless of the form of involuntary care, control over treatment can be continued according to necessity criteria in the law in order to prevent deterioration. For these reasons, the rate of persons affected by involuntary admission and/or CTO per 100 000 capita will be used as an indicator of use of involuntary care in the catchment area and hence, the main covariate.
The age span will be patients from 18 to 65, so that the increasing frequency of involuntary care due to lack of capacity due to dementia towards the end of life will not impact the results. The investigators will control for age and sex by indirect standardization, based on Statistics Norway's tables for population in municipalities and city districts.
The investigators will test whether the living condition index and/or urbanity of the municipality (perhaps merged to fewer categories than five) predict rates of involuntary care. A classification of all municipalities into five degrees of urbanity from a previous study will be used. Statistics Norway published an index of living conditions in Norwegian municipalities and City districts in 2000 and 2008, which has not been continued after 2008. This index combines the level or frequency of a variety of social benefit payments, unemployment, education level and lethality, and should be sufficiently up to date. If urbanity or living condition predicts rates of involuntary care, it will be controlled for by estimating a suitable linear regression model. A hierarchical model adjusting for nesting of municipalities within CMHCs and CMHCs within health trusts will be considered, but this adjustment may be reduced based on intraclass correlations. Then the ratio between expected and observed use of involuntary care will be the main covariate, and will reflect the rate of involuntary care per capita, controlled for age, sex and urbanity and deprivation in each catchment area. Each patient in the dataset will be assigned the value of this covariate corresponding to their area of residence in 2015.
The first group of models is assessing associations between the main covariate measured in the index year and survival or change in outcome variables in the following years for the patients included.
Model 1. Are there more deaths among SMD patients from areas with low levels of involuntary care?
The main covariate is rate of involuntary care in 69 areas in 2015, controlled for age, sex, urbanity and deprivation. The unit of analysis is the individual patient with a care episode and a registered SMD diagnosis in 2015. Outcome variable is time to death from the quarter in 2015 with a registered event with a SMD-diagnosis, observed through 2018. The unit of analysis is the individual SMD patient. The statistical method is survival analysis with adjustment for age and sex and adjustment for random effects.
Model 2. Is there increased use of inpatient care for voluntary SMD-patients from areas with low levels of involuntary care?
The main covariate is rate of involuntary mental health care in 69 areas in 2015, controlled for age, sex, urbanity and deprivation. The unit of analyses is the individual SMD-patient with 'voluntary care only' in 2015. The outcome variable is change in mental health inpatient days in the next two years for the included patients. The statistical method is a linear mixed model with random effects for CMHC.
Model 3. Is there decreased time to the next episode of involuntary care for voluntary SMD-patients from areas with low levels of involuntary care? The main covariate is rate of involuntary mental health care in the 69 areas in 2015, controlled for age, sex, urbanity and deprivation. The unit of analyses is the individual SMD-patient with 'voluntary care only' in 2015. Outcome variable are time to a treatment episode with involuntary care observed through 2016 and 2017. The statistical method is survival analysis with death as competing risk with random effects for catchment area.
Model 4 and 5 are ecological models of the catchment areas.
Model 4. Are low levels of involuntary care in a catchment area followed by more SMD patients in the area? The main covariate is rate of involuntary mental health care in the 69 areas in 2015, controlled for age, sex, urbanity and deprivation. The outcome variable is the change in annual number of patients with SMD in 2016 and 2017. The unit of analysis is the catchment area (N=69). The statistical method is linear regression model with time, main covariate and interaction between the two as independent variables.
Model 5. Is low level of involuntary care in an area related to more suicides?
The main covariate is rate of involuntary care in 2015-2018 in the 69 areas, controlled for age, sex, urbanity and deprivation. The outcome variable is the standardized rate of suicides in the area's population regardless of patient status, from 2015 through 2019. The unit of analysis is the 69 catchment areas. Due to low incidence of the outcome, merging of some areas will be considered. The statistical method is correlation analysis.
Dissemination: Study results will be published study international peer-reviewed scientific journals. The number of papers necessary to disseminate results depends of the complexity of results and their interpretation.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 3 Years
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Norwegian adults from 18-65 years that had at least one specialist inpatient or outpatient treatment episode with a registered diagnosis of F20-31 according to International Classification of Diseases (ICD-10) in 2015. Persons without permanent residence in Norway is excluded. The sample is the full target population, based on a mandatory national patient registry.
Key inclusion criteria (1 listed)
- The person received treatment for ICD-10 codes F20-31 in Norwegian health trusts 2015
Key exclusion criteria (2 listed)
- Persons without permanent address in Norway (tourists)
- For models 2 and 3, patients receiving involuntary mental health care in 2015 is excluded
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Time to death
Time frame: 2015-2017
Time to death for patients with a severe mental disorder in 2015, as a function of the rate of involuntary care for the patient's area of residence in 2015
Mental health inpatient days
Time frame: 2015-2017
Time trends in mental health inpatient days from 2015-2017 for patients with a severe mental disorder but no involuntary care in 2015, as a function of the rate of involuntary care for the patient's area of residence in 2015
Episode of involuntary care
Time frame: 2015-2017
Time to an episode of involuntary care for patients with a severe mental disorder and no involuntary care in 2015, as a function of the rate of involuntary care for the patient's area of residence in 2015
Number of patients with severe mental disorders
Time frame: 2015-2017
Time trends in the rate of severe mental disorders in 69 catchment areas as a function of their rates of involuntary care in 2015-2018
Number of suicides
Time frame: 2015-2019
Standardized rate of suicides in 60 catchment areas in 2015-2019, as a function of rates of involuntary care in 2015-2018
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2025.
- Derived from this study: PubMed 36803444Nyttingnes O, Benth JS, Hofstad T, Rugkasa J. The relationship between area levels of involuntary psychiatric care and patient outcomes: a longitudinal national register study from Norway. BMC Psychiatry. 2023 Feb 20;23(1):112. doi: 10.1186/s12888-023-04584-4.
- The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines.Link provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Schizophrenia and Related Disorders
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruitingObservational study
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)
Not yet recruitingPhase 1
Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants
Healthy Adult Participants
Recruiting
REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
Schizophrenia, Schizo Affective Disorder
RecruitingPhase 3
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Schizophrenia, Bipolar Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jorun Rugkåsa, PhD principal investigator
University Hospital, Akershus
Questions about this trial
What is this clinical trial studying?
An observational study of Schizophrenia and Related Disorders and Bipolar Disorder, run by University Hospital, Akershus.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to death (time frame: 2015-2017). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04655287, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2025.